Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2024-12-04

Clinical Trial Update: tDCS to Decrease Opioid Relapse (UH3) [NA]

View source ↗

Summary

A clinical trial investigating transcranial direct current stimulation (tDCS) to reduce opioid relapse is currently recruiting at Butler Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Butler Hospital | Conditions: Opioid Use Disorder | NA | Status: RECRUITING